These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 10487950)

  • 1. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.
    Kurahara S; Shinohara M; Ikebe T; Nakamura S; Beppu M; Hiraki A; Takeuchi H; Shirasuna K
    Head Neck; 1999 Oct; 21(7):627-38. PubMed ID: 10487950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
    Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
    Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
    O-Charoenrat P; Rhys-Evans PH; Eccles SA
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):813-20. PubMed ID: 11448356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
    Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
    J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.
    Mashhadiabbas F; Mahjour F; Mahjour SB; Fereidooni F; Hosseini FS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):240-50. PubMed ID: 22769410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
    Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
    Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
    Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y
    Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of MMPs and TIMPs on the metastasis of oral squamous cell carcinoma to neck lymph nodes].
    Liu G; Li J; Li Z; Chen X
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Aug; 19(4):216-8, 224. PubMed ID: 12539723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer.
    Shim KN; Jung SA; Joo YH; Yoo K
    J Gastroenterol; 2007 Feb; 42(2):120-8. PubMed ID: 17351800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
    Katayama A; Bandoh N; Kishibe K; Takahara M; Ogino T; Nonaka S; Harabuchi Y
    Clin Cancer Res; 2004 Jan; 10(2):634-40. PubMed ID: 14760086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
    Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
    Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
    Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
    de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
    J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined evaluation of matrix metalloproteinases and their inhibitors has better clinical utility in oral cancer.
    Singh RD; Nilayangode H; Patel JB; Shah FD; Shukla SN; Shah PM; Patel PS
    Int J Biol Markers; 2011; 26(1):27-36. PubMed ID: 21337314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoexpression of matrix metalloproteinases and their inhibitors in different areas of oral squamous cell carcinoma.
    Suarez-Roa ML; Asbun-Bojalil J; Ruiz-Godoy LM; Meneses-García AA
    Aust Dent J; 2012 Sep; 57(3):300-7. PubMed ID: 22924352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of metalloproteinases 2 and 9 and tissue inhibitors 1 and 2 as predictors of lymph node metastases in oropharyngeal squamous cell carcinoma.
    Burduk PK; Bodnar M; Sawicki P; Szylberg Ł; Wiśniewska E; Kaźmierczak W; Martyńska M; Marszałek A
    Head Neck; 2015 Mar; 37(3):418-22. PubMed ID: 24436008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The matrix metalloproteinase system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.